# Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery

> **NCT04200651** · PHASE4 · TERMINATED · sponsor: **The New York Eye Surgery Center** · enrollment: 25 (actual)

## Conditions studied

- Glaucoma
- Cataract

## Interventions

- **DRUG:** Dexamethasone Ophthalmic Insert
- **DRUG:** Prednisolone Acetate 1% Oph Susp

## Key facts

- **NCT ID:** NCT04200651
- **Lead sponsor:** The New York Eye Surgery Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-13
- **Primary completion:** 2023-07-12
- **Final completion:** 2023-07-12
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** COVID-19 challenges to recruitment
- **Last updated:** 2024-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04200651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04200651, "Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04200651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*